Get startedLog in
    Picture of GI Innovation logo

    358570 — GI Innovation Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for GI Innovation, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-75,933-150,742-79,833-55,022-59,007
    Depreciation
    Amortisation
    Non-Cash Items55,417124,77817,4718,92714,998
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital4,156-2,761-3,3451,592-2,519
    Change in Accounts Receivable
    Change in Other Assets
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-15,182-26,577-62,550-41,174-43,427
    Capital Expenditures-3,213-4,922-2,970-579-24.7
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-8,121-134,24965,95422,84215,275
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-11,334-139,17162,98422,26315,250
    Financing Cash Flow Items30,700-62.5—-801-140
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities31,435161,492-32.125,10920,617
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash4,919-4,2564026,198-7,560